These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 12416395)

  • 1. Neuropathology of variant Creutzfeldt-Jakob disease.
    Ironside JW; Head MW; McCardle L; Knight R
    Acta Neurobiol Exp (Wars); 2002; 62(3):175-82. PubMed ID: 12416395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laboratory diagnosis of variant Creutzfeldt-Jakob disease.
    Ironside JW; Head MW; Bell JE; McCardle L; Will RG
    Histopathology; 2000 Jul; 37(1):1-9. PubMed ID: 10931212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathological diagnosis of variant Creutzfeldt-Jakob disease.
    Ironside JW; McCardle L; Horsburgh A; Lim Z; Head MW
    APMIS; 2002 Jan; 110(1):79-87. PubMed ID: 12064259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropathology of variant Creutzfeldt-Jakob disease.
    Ironside JW
    C R Biol; 2002 Jan; 325(1):27-31. PubMed ID: 11862618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropathology and molecular biology of variant Creutzfeldt-Jakob disease.
    Ironside JW; Head MW
    Curr Top Microbiol Immunol; 2004; 284():133-59. PubMed ID: 15148991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathology of variant Creutzfeldt-Jakob disease.
    Ironside JW
    Arch Virol Suppl; 2000; (16):143-51. PubMed ID: 11214917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the neuropathological characteristics of bovine spongiform encephalopathy (BSE) and variant Creutzfeldt-Jakob disease (vCJD) in mice.
    Brown DA; Bruce ME; Fraser JR
    Neuropathol Appl Neurobiol; 2003 Jun; 29(3):262-72. PubMed ID: 12787323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guinea Pig Prion Protein Supports Rapid Propagation of Bovine Spongiform Encephalopathy and Variant Creutzfeldt-Jakob Disease Prions.
    Watts JC; Giles K; Saltzberg DJ; Dugger BN; Patel S; Oehler A; Bhardwaj S; Sali A; Prusiner SB
    J Virol; 2016 Nov; 90(21):9558-9569. PubMed ID: 27440899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variant Creutzfeldt-Jakob disease: immunocytochemical studies and image analysis.
    Nailon WH; Ironside JW
    Microsc Res Tech; 2000 Jul; 50(1):2-9. PubMed ID: 10871542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PMCA Applications for Prion Detection in Peripheral Tissues of Patients with Variant Creutzfeldt-Jakob Disease.
    Giaccone G; Moda F
    Biomolecules; 2020 Mar; 10(3):. PubMed ID: 32151109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study protocol for enhanced CJD surveillance in the 65+ years population group in Scotland: an observational neuropathological screening study of banked brain tissue donations for evidence of prion disease.
    Peden AH; Kanguru L; Ritchie DL; Smith C; Molesworth AM
    BMJ Open; 2019 Oct; 9(10):e033744. PubMed ID: 31662408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological phenotype of codon 129 valine homozygote sporadic Creutzfeldt-Jakob disease.
    Kovacs GG; Head MW; Bunn T; Laszlo L; Will RG; Ironside JW
    Neuropathol Appl Neurobiol; 2000 Oct; 26(5):463-72. PubMed ID: 11054187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropathological and biochemical criteria to identify acquired Creutzfeldt-Jakob disease among presumed sporadic cases.
    Kobayashi A; Parchi P; Yamada M; Mohri S; Kitamoto T
    Neuropathology; 2016 Jun; 36(3):305-10. PubMed ID: 26669818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Creutzfeldt-Jakob disease, prion protein gene codon 129VV, and a novel PrPSc type in a young British woman.
    Mead S; Joiner S; Desbruslais M; Beck JA; O'Donoghue M; Lantos P; Wadsworth JD; Collinge J
    Arch Neurol; 2007 Dec; 64(12):1780-4. PubMed ID: 18071044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropathological findings in new variant CJD and experimental transmission of BSE.
    Ironside JW
    FEMS Immunol Med Microbiol; 1998 Jun; 21(2):91-5. PubMed ID: 9684997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective Effect of Val
    Fernández-Borges N; Espinosa JC; Marín-Moreno A; Aguilar-Calvo P; Asante EA; Kitamoto T; Mohri S; Andréoletti O; Torres JM
    Emerg Infect Dis; 2017 Sep; 23(9):1522-1530. PubMed ID: 28820136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct pathological phenotypes of Creutzfeldt-Jakob disease in recipients of prion-contaminated growth hormone.
    Cali I; Miller CJ; Parisi JE; Geschwind MD; Gambetti P; Schonberger LB
    Acta Neuropathol Commun; 2015 Jun; 3():37. PubMed ID: 26108478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal prion protein in the pituitary in sporadic and variant Creutzfeldt-Jakob disease.
    Peden AH; Ritchie DL; Uddin HP; Dean AF; Schiller KAF; Head MW; Ironside JW
    J Gen Virol; 2007 Mar; 88(Pt 3):1068-1072. PubMed ID: 17325383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of variant Creutzfeldt-Jakob disease prions in prion protein-humanized mice carrying distinct codon 129 genotypes.
    Takeuchi A; Kobayashi A; Ironside JW; Mohri S; Kitamoto T
    J Biol Chem; 2013 Jul; 288(30):21659-66. PubMed ID: 23792955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variant CJD. 18 years of research and surveillance.
    Diack AB; Head MW; McCutcheon S; Boyle A; Knight R; Ironside JW; Manson JC; Will RG
    Prion; 2014; 8(4):286-95. PubMed ID: 25495404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.